Back to top

zacks-rank: Archive

Zacks Equity Research

Applied Materials (AMAT) Q2 Earnings and Revenues Surpass Estimates

Applied Materials (AMAT) delivered earnings and revenue surprises of 6.09% and 2.04%, respectively, for the quarter ended April 2024. Do the numbers hold clues to what lies ahead for the stock?

AMATNegative Net Change VEEVNegative Net Change

Zacks Equity Research

DXC Technology Company. (DXC) Q4 Earnings and Revenues Top Estimates

DXC Technology (DXC) delivered earnings and revenue surprises of 16.87% and 0.42%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

DXCPositive Net Change SCWXPositive Net Change

Zacks Equity Research

Copart, Inc. (CPRT) Q3 Earnings and Revenues Surpass Estimates

Copart (CPRT) delivered earnings and revenue surprises of 2.63% and 1.79%, respectively, for the quarter ended April 2024. Do the numbers hold clues to what lies ahead for the stock?

CPRTNegative Net Change PAGSPositive Net Change

Zacks Equity Research

Globant (GLOB) Matches Q1 Earnings Estimates

Globant (GLOB) delivered earnings and revenue surprises of 0% and 0.06%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

GLOBNegative Net Change OKTAPositive Net Change

Zacks Equity Research

Flowers Foods (FLO) Q1 Earnings and Revenues Miss Estimates

Flowers Foods (FLO) delivered earnings and revenue surprises of -5% and 0.10%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

FLONegative Net Change UNFIPositive Net Change

Zacks Equity Research

Doximity (DOCS) Q4 Earnings and Revenues Surpass Estimates

Doximity (DOCS) delivered earnings and revenue surprises of 25% and 1.37%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

DOCSNegative Net Change ICCMNegative Net Change

Zacks Equity Research

Why Super Group (SGHC) (SGHC) Might be Well Poised for a Surge

Super Group (SGHC) (SGHC) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

SGHCPositive Net Change

Zacks Equity Research

Can SilverCrest Metals (SILV) Run Higher on Rising Earnings Estimates?

SilverCrest Metals (SILV) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

SILVNegative Net Change

Zacks Equity Research

Can Oddity Tech (ODD) Run Higher on Rising Earnings Estimates?

Oddity Tech (ODD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

ODDNegative Net Change

Zacks Equity Research

Earnings Estimates Moving Higher for Robinhood Markets (HOOD): Time to Buy?

Robinhood Markets (HOOD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

HOODNegative Net Change

Zacks Equity Research

Earnings Estimates Moving Higher for Synchronoss (SNCR): Time to Buy?

Synchronoss (SNCR) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

SNCRPositive Net Change

Zacks Equity Research

Earnings Estimates Moving Higher for Green Brick Partners (GRBK): Time to Buy?

Green Brick Partners (GRBK) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

GRBKNegative Net Change

Zacks Equity Research

Will B2Gold (BTG) Gain on Rising Earnings Estimates?

B2Gold (BTG) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

BTGNegative Net Change

Zacks Equity Research

Costamare (CMRE) Upgraded to Strong Buy: What Does It Mean for the Stock?

Costamare (CMRE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

CMREPositive Net Change

Zacks Equity Research

All You Need to Know About Aptiv (APTV) Rating Upgrade to Strong Buy

Aptiv (APTV) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

APTVPositive Net Change

Zacks Equity Research

All You Need to Know About Passage Bio (PASG) Rating Upgrade to Buy

Passage Bio (PASG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

PASGPositive Net Change

Zacks Equity Research

Hanover Insurance (THG) Upgraded to Buy: Here's Why

Hanover Insurance (THG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

THGPositive Net Change

Zacks Equity Research

Camtek (CAMT) Moves to Strong Buy: Rationale Behind the Upgrade

Camtek (CAMT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

CAMTNegative Net Change

Zacks Equity Research

What Makes ResMed (RMD) a New Strong Buy Stock

ResMed (RMD) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

RMDNegative Net Change

Zacks Equity Research

StoneCo (STNE) Upgraded to Buy: What Does It Mean for the Stock?

StoneCo (STNE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

STNENegative Net Change

Zacks Equity Research

All You Need to Know About Carrols Restaurant (TAST) Rating Upgrade to Buy

Carrols Restaurant (TAST) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

TASTNo Net Change

Zacks Equity Research

Milestone Pharmaceuticals (MIST) Upgraded to Buy: Here's What You Should Know

Milestone Pharmaceuticals (MIST) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

MISTPositive Net Change

Zacks Equity Research

Palmer Square Capital BDC Inc. (PSBD) Upgraded to Strong Buy: What Does It Mean for the Stock?

Palmer Square Capital BDC Inc. (PSBD) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

PSBDPositive Net Change

Zacks Equity Research

Dillard's (DDS) Tops Q1 Earnings and Revenue Estimates

Dillard's (DDS) delivered earnings and revenue surprises of 19.89% and 1.19%, respectively, for the quarter ended April 2024. Do the numbers hold clues to what lies ahead for the stock?

DDSNegative Net Change KSSNegative Net Change

Zacks Equity Research

Global Ship Lease (GSL) Tops Q1 Earnings and Revenue Estimates

Global Ship Lease (GSL) delivered earnings and revenue surprises of 8.12% and 5.19%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

GSLPositive Net Change EDRYPositive Net Change